Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MSP 3 Long Synthetic Peptide
BIOLOGICAL
2 trials
Sponsors
African Malaria Network Trust
Conditions
Malaria
Phase 1
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
NCT00452088
African Malaria Network Trust
Malaria
Start: 2007-04-30
End: 2008-05-31
Target: 45
Updated: 2008-05-07
Phase Ib Trial of MSP3 LSP in Children in Tanzania
NCT00469651
African Malaria Network Trust
Malaria
Start: 2007-10-31
End: 2008-08-31
Target: 45
Updated: 2007-12-14
Related Papers
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
2009-10-26
38 citations
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.
2009-07-17
23 citations